{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:13:39Z","timestamp":1753877619400,"version":"3.41.2"},"reference-count":7,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:00:00Z","timestamp":1733788800000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>A 67-year-old lady was admitted with, right sided weakness and right arm shaking. She had recently completed a course of Linezolid for a diabetic foot infection and osteomyelitis. Prior to this she had prodromal symptoms including lethargy and loss of appetite. Clinical features prompting presentation included global weakness, verbal dysfluency and visual disturbance. MRI brain showed bilateral alteration of signal in the deep white matter of the posterior frontal and parietal lobes, sparing the superficial cortical areas. These areas showed diffusion restriction, suggestive of, but not limited to, ischaemic stroke. During admission she had a decline in consciousness and was hypertensive. An acute drop in haemoglobin and platelets occurred prompting consideration of Thrombotic Microangiopathy and other drug related\/malignant\/infective aetiologies. A diagnosis of Linezolid induced Acute Toxic Leukoencephalopathy and thrombocytopenia was made based on clinico-radiographic features and exclusion of other causes.<\/jats:p>","DOI":"10.1093\/omcr\/omae150","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T02:12:55Z","timestamp":1733883175000},"source":"Crossref","is-referenced-by-count":0,"title":["Linezolid induced acute toxic leukoencephalopathy and severe thrombocytopenia presenting as stroke mimic\u2014a case report"],"prefix":"10.1093","volume":"2024","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9829-2758","authenticated-orcid":false,"given":"S","family":"Ahmed","sequence":"first","affiliation":[{"name":"Rheumatology, Addenbrookes Hospital , Hills Road, Cambridge, CB2 0QQ,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1411-0719","authenticated-orcid":false,"given":"G","family":"Hayman","sequence":"additional","affiliation":[{"name":"Rheumatology, Addenbrookes Hospital , Hills Road, Cambridge, CB2 0QQ,","place":["United Kingdom"]},{"name":"General Practice Specialty Training, Colchester Hospital, East Suffolk and North Essex NHS Foundation Trust , Turner Road, Colchester, CO4 5JL,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5719-0990","authenticated-orcid":false,"given":"S","family":"Moin","sequence":"additional","affiliation":[{"name":"General Medicine, Hillingdon Hospital NHS Trust , Pield Heath Rd, UxbridgeUB8 3NN","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Ubaide","sequence":"additional","affiliation":[{"name":"General Medicine, Colchester Hospital, East Suffolk and North Essex NHS Foundation Trust , Turner Road, Colchester, CO4 5JL,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Sivakumar","sequence":"additional","affiliation":[{"name":"Stroke Medicine, Colchester Hospital, East Suffolk and North Essex NHS Foundation Trust, Turner Road, Colchester , CO4 5JL,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Padayatty","sequence":"additional","affiliation":[{"name":"Haematology, Colchester Hospital, East Suffolk and North Essex NHS Foundation Trust , Turner Road, Colchester,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,12,10]]},"reference":[{"key":"2024121101375359700_ref1","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1001\/archneur.64.5.746","article-title":"Linezolid-induced posterior reversible leukoencephalopathy syndrome","volume":"64","author":"Nagel","year":"2007","journal-title":"Arch Neurol"},{"key":"2024121101375359700_ref2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijantimicag.2017.01.027","article-title":"Complications associated with antibiotic administration: neurological adverse events and interference with antiepileptic drugs","volume":"50","author":"Esposito","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"2024121101375359700_ref3","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1111\/bcp.13262","article-title":"Population pharmacokinetics and pharmacodynamics of linezolid-induced thrombocytopenia in hospitalized patients","volume":"83","author":"Tsuji","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"2024121101375359700_ref4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJM200108093450606","article-title":"Toxic leukoencephalopathy","volume":"345","author":"Filley","year":"2001","journal-title":"N Engl J Med"},{"key":"2024121101375359700_ref5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3174\/ajnr.A5947","article-title":"Acute toxic leukoencephalopathy: etiologies, imaging findings, and outcomes in 101 patients","volume-title":"AJNR Am J Neuroradiol","author":"\u00d6z\u00fctemiz","year":"2019"},{"key":"2024121101375359700_ref6","doi-asserted-by":"publisher","first-page":"192","DOI":"10.2214\/AJR.08.1176","article-title":"Acute toxic leukoencephalopathy: potential for reversibility clinically and on MRI with diffusion-weighted and FLAIR imaging","volume":"193","author":"McKinney","year":"2009","journal-title":"AJR Am J Roentgenol"},{"key":"2024121101375359700_ref7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3389\/fphar.2016.00325","article-title":"Linezolid toxicity and mitochondrial susceptibility: a novel neurological complication in a Lebanese patient","volume":"7","author":"Abou Hassan","year":"2016","journal-title":"Front Pharmacol"}],"container-title":["Oxford Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/omcr\/article-pdf\/2024\/12\/omae150\/61015735\/omae150.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/omcr\/article-pdf\/2024\/12\/omae150\/61015735\/omae150.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T02:12:57Z","timestamp":1733883177000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/omcr\/article\/doi\/10.1093\/omcr\/omae150\/7919845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":7,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12,10]]}},"URL":"https:\/\/doi.org\/10.1093\/omcr\/omae150","relation":{},"ISSN":["2053-8855"],"issn-type":[{"type":"electronic","value":"2053-8855"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,12]]},"article-number":"omae150"}}